StockData
Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc. (LNTH) stock

LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3014% above fair value
$102.00+0.20 (+0.20%)

Close on Nov 18, 2026Market cap $6.66BP/E 24.7Yield –

Lantheus revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Lantheus's revenue for the twelve months ending Jun 30, 2026 was $1.56B, up 2.3% year over year. For fiscal 2025 it was $1.54B, up 0.5% from the year before. Over ten years it grew 18.0% a year on average. The highest annual figure on record is $1.54B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.54B+0.5%
FY2024Dec 31, 2024$1.53B+18.3%
FY2023Dec 31, 2023$1.30B+38.6%
FY2022Dec 31, 2022$935.06M+119.9%
FY2021Dec 31, 2021$425.21M+25.3%
FY2020Dec 31, 2020$339.41M-2.3%
FY2019Dec 31, 2019$347.34M+1.2%
FY2018Dec 31, 2018$343.37M+3.6%
FY2017Dec 31, 2017$331.38M+9.8%
FY2016Dec 31, 2016$301.85M+2.9%
FY2015Dec 31, 2015$293.46M-2.7%
FY2014Dec 31, 2014$301.60M+6.3%
FY2013Dec 31, 2013$283.67M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$388.18M+2.7%
Q1 FY2026Mar 31, 2026$377.33M+1.2%
Q4 FY2025Dec 31, 2025$406.79M+4.0%
Q3 FY2025Sep 30, 2025$384.01M+1.4%
Q2 FY2025Jun 30, 2025$378.05M-4.1%
Q1 FY2025Mar 31, 2025$372.76M+0.8%
Q4 FY2024Dec 31, 2024$391.11M+10.5%
Q3 FY2024Sep 30, 2024$378.73M+18.4%
Q2 FY2024Jun 30, 2024$394.09M+22.5%
Q1 FY2024Mar 31, 2024$369.98M+23.0%
Q4 FY2023Dec 31, 2023$354.00M+34.5%
Q3 FY2023Sep 30, 2023$319.95M+33.7%
Q2 FY2023Jun 30, 2023$321.70M+43.8%
Q1 FY2023Mar 31, 2023$300.78M+44.0%
Q4 FY2022Dec 31, 2022$263.17M+103.1%
Q3 FY2022Sep 30, 2022$239.29M+134.4%
Q2 FY2022Jun 30, 2022$223.72M+121.4%
Q1 FY2022Mar 31, 2022$208.88M+125.8%
Q4 FY2021Dec 31, 2021$129.56M+37.6%
Q3 FY2021Sep 30, 2021$102.07M+15.3%
Q2 FY2021Jun 30, 2021$101.06M+53.1%
Q1 FY2021Mar 31, 2021$92.51M+2.0%
Q4 FY2020Dec 31, 2020$94.15M+5.4%
Q3 FY2020Sep 30, 2020$88.54M+3.2%
Q2 FY2020Jun 30, 2020$66.01M-23.0%
Q1 FY2020Mar 31, 2020$90.70M+4.8%
Q4 FY2019Dec 31, 2019$89.35M+3.6%
Q3 FY2019Sep 30, 2019$85.78M-3.5%
Q2 FY2019Jun 30, 2019$85.71M+0.2%
Q1 FY2019Mar 31, 2019$86.51M+4.7%
Q4 FY2018Dec 31, 2018$86.27M+6.2%
Q3 FY2018Sep 30, 2018$88.90M+11.2%
Q2 FY2018Jun 30, 2018$85.57M-3.7%
Q1 FY2018Mar 31, 2018$82.63M+1.6%
Q4 FY2017Dec 31, 2017$81.24M+9.3%
Q3 FY2017Sep 30, 2017$79.94M+9.4%
Q2 FY2017Jun 30, 2017$88.84M–
Q1 FY2017Mar 31, 2017$81.36M–
Q4 FY2016Dec 31, 2016$74.35M–
Q3 FY2016Sep 30, 2016$73.06M–

More Lantheus figures

See a number that looks wrong?